|
1 |
Prevalence and predictors of positive airway pressure therapy prescription in obstructive sleep apnoea: a population-representative study
Enthalten in Somnologie 19.12.2023: 1-8
|
|
|
|
2 |
Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical Trial
Enthalten in Respiration Bd. 100, 2021, Nr. 12: 1174-1185. 12 S.
|
|
|
3 |
C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: a bi-center study
Riedl, Jakob M.. - Augsburg : Universität Augsburg, 2020
|
|
|
|
4 |
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial
Barco, Stefano. - Augsburg : Universität Augsburg, 2020
|
|
|
|
5 |
Wenn CPAP nicht genutzt oder nicht vertragen wird – Vorschlag für eine standardisierte Terminologie
Enthalten in Somnologie 3.2.2020: 1-4
|
|
|
|
6 |
Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study
Brückl, Wolfgang M.. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2018
|
|
|
|
7 |
Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause
Enthalten in RöFo Bd. 189, 2017, Nr. 05: 423-430
|
|
|
|
8 |
Telemedicine-based proactive patient management during positive airway pressure therapy
Enthalten in Somnologie 23.1.2017: 1-7
|
|
|
|
9 |
Adherence to Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea: Impact of Patient Education after a Longer Treatment Period
Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2013
|
|
|
|
10 |
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
Enthalten in BMC cancer Bd. 20, 3.12.2020, Nr. 1, date:12.2020: 1-16
|
|
Administration
